
Actor Dipika Kakar undergoes mammography: Do women cancer survivors need to continue their mammograms?
In a vlog, Kakar says that she consulted the doctor after she developed pain on her left side. Her first mammogram showed enlarged lymph nodes, which can arise from various reasons, including infection. Her doctor had said then that it didn't look suspicious but it would be good to do a repeat scan after three months. Other doctors said the pain could be the result of a muscle injury. She mentioned how, because of her surgery and her recovery, her time to get the mammography done had exceeded three months. Now the mammography has shown that her lymph nodes had shrunk.
'Women cancer survivors need to watch out for spread or recurrence once they are on follow-up therapy protocol. And that's why a mammogram is advised. Generally, we do not advise mammography alongside PET scan (which assesses spread, metastasis and treatment response) because any anomaly would automatically be picked up by the latter. We do not suggest it for all liver cancer survivors either without assessing individual cases and risks. But in cases of breast cancer, some survivors may be suggested to undergo mammography surveillance even while undergoing PET scans,' says Dr Jeyhan Dhabhar, consultant, medical oncology, Jaslok Hospital, Mumbai.
No matter where you develop cancer, you need surveillance through imaging tests of the breast. Unless the woman is a breast cancer survivor, we suggest mammograms to women survivors of other cancers only after they have completed their treatment protocol. Once they are on routine follow-up, we suggest mammography once in 12 to 18 months, the same as we advise any woman over the age of 45.
However if the women are BRCA-positive, then there is a different screening protocol even if they develop cancer in any other part of the body.
BRCA-positive women have a higher lifetime risk of developing breast and ovarian cancers due to inherited mutations in the BRCA1 or BRCA2 genes. Women with BRCA1 mutations have a 72% lifetime risk of breast cancer, while those with BRCA2 mutations have a 69% risk. Ovarian cancer risk also increases.
So if a BRCA-positive woman has recovered from cancer in another part of the body, we recommend breast sonography once in six months and an MRI breast once in six months for monitoring purposes. Breast ultrasound uses sound waves to create images and are often used to further investigate abnormalities found during mammograms.
Once they are through with the treatment protocol, they should because mammograms can tell you about breast tissue anomalies or new growth. While breast cancer can sometimes spread to the liver, liver cancer does not directly increase the risk of breast cancer.
You need to screen for new growth. Especially if you've only had one breast removed, you should be screening the other breast to rule out abnormal tissue growth.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
15 hours ago
- News18
Best Cancer Screening Tests For Women In 2025
Breast cancer screening holds the power to transform outcomes dramatically. While international guidelines provide a strong foundation, local adaptation is essential. Breast cancer continues to be the most commonly diagnosed cancer among women in India, surpassing cervical cancer over the past decade. Global guidelines now emphasize risk-based screening over one- size-fits-all approaches. This includes taking family history, genetics, menstrual and reproductive history, lifestyle, and breast density into account. With increasing awareness, evolving technologies, and more robust global and Indian data, 2025 marks a pivotal year in how we think about breast cancer screening. Dr Karishma Kirti, Consultant Breast Specialist and Oncoplastic Surgeon shares all you need to know: International bodies such as the American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF) now recommend: 1. Mammography beginning at age 40 for average-risk women 2. Annual or biennial mammograms depending on individual risk and access 3. 3D digital mammography (tomosynthesis) for improved detection where available 4. Earlier screening from age 30–35 for high-risk individuals (e.g. BRCA1/2 mutation carriers) India's breast cancer landscape is distinct as a significant proportion of cases are seen in women under 50, late-stage presentation is more common, especially in public hospitals and mammography access remains uneven, particularly outside major cities. One of the most important contributions to global breast cancer screening evidence actually comes from India itself. The Mumbai cluster randomized controlled trial, followed nearly 150,000 women over 20 years. It demonstrated that biennial clinical breast examination (CBE) by trained female health workers led to a significant stage shift to earlier detection. Among women aged 50 and above, there was a 15% reduction in breast cancer mortality. CBE was found to be low-cost, acceptable, and scalable. (Mittra I, et al. Lancet Oncol. 2021;22(3):402–15.) This study offers conclusive, real-world evidence that CBE, when done systematically with proper follow- up, saves lives especially in low- and middle-income countries (LMICs) like India. What about breast self-examination? While breast self-exams are no longer formally recommended for screening in the West, breast awareness knowing what's normal for you is still vital in India. Encouraging monthly self-checks and timely reporting of lumps or changes can lead to earlier diagnosis. Many women first discover their cancer themselves, not through screening, but by noticing a lump or change. In the absence of national guidelines, these are some of the recommendations I use in my clinic to guide my patients through screening for breast cancer. This tiered, risk-based approach is based on both the evidence and the ground realities of healthcare access in India. Breast cancer screening holds the power to transform outcomes dramatically. While international guidelines provide a strong foundation, local adaptation is essential. For Indian women, the best approach combines: Early vigilance, Accessible technology, and Open conversations around breast health. The earlier we detect, the more lives we save. The News18 Lifestyle section brings you the latest on health, fashion, travel, food, and culture — with wellness tips, celebrity style, travel inspiration, and recipes. Also Download the News18 App to stay updated! view comments Location : New Delhi, India, India First Published: July 22, 2025, 19:23 IST News lifestyle » health-and-fitness Best Cancer Screening Tests For Women In 2025 Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


Time of India
18 hours ago
- Time of India
Prostate Cancer: Why are we ignoring prostate cancer? The silent epidemic affecting millions of men
It's time we discuss something that often flies under the radar in our homes, clinics, and chatter — prostate cancer. This condition, which strikes millions of men worldwide, continues to grow in prevalence, particularly in nations like India where awareness is in infancy. Tired of too many ads? go ad free now The silent intruder Prostate cancer starts in the prostate gland, which is one of the accessory gland of the male sex situated just beneath the bladder and ahead of the rectum. It has an important role along with seminal vesicle in male fertility, secreting seminal fluid that nourishes sperm and carries sperm. What is so risky about prostate cancer is that it can go on silently, particularly during its initial stages. Most men do not have symptoms until the cancer has progressed. Indeed, some are diagnosed by chance while undergoing standard health examinations or testing for other ailments. Identifying the symptoms Despite early prostate cancer not having symptoms, men should note warning signs that include: ● Frequent urination, particularly at night ● Straining or inability to start or stop urination ● Weakened or interrupted stream of urine ● Painful or burning sensation on urination ● Blood in urine or semen ● Pelvic, back, or hip pain (indicative of more advanced disease) It is noteworthy that the symptoms can also be due to benign prostatic hyperplasia (BPH) or urinary tract infection. But neglecting them or attributing them to it's "just age catching up" can lead to delayed diagnosis and treatment. Who's at risk? Though prostate cancer is diagnosed most frequently in men above the age of 50 years, some conditions raise the risk: ● Age: Risk becomes a lot higher after 50 years. Median age at diagnosis moved to 67 from 70 years a decade ago. ● Hereditary: >3 such cases in the same family or > 2 such cases diagnosed < 55 years have a high risk. Tired of too many ads? go ad free now ● Family history: 2 first-degree relatives or 1 first degree relative and > 2 second degree relative are at high risk. ● Genetic - Germline mutations such as BRCA2, HOXB13, BRCA1, CHEK2, ATM, MMR genes etc ● Race: African and Afro-Caribbean men are at higher risk, although data in Indian men is increasing ● Lifestyle: Metabolic syndrome, Alcohol, High fried food diet, red and processed meat and obesity have been linked to increased risk Diagnosis and screening Globally, the Prostate-Specific Antigen (PSA) blood test and Digital Rectal Examination (DRE) are the primary tools for screening. Though these are not foolproof diagnostic methods, they help identify men who may require further evaluation. Once there is suspicion, imaging examinations such as mpMRI - multiparametric MRI, and a prostate biopsy (in which a small amount of tissue is checked for cancer cells), are employed to establish the diagnosis. No national screening program exists in India, and routine screening is not practiced for all due to overdiagnosis concerns. Yet, for men over 50 — or 45 if there is a family history — yearly screening can be lifesaving. Modern treatment strategies Treatment varies by stage and grade of cancer, along with the patient's age, overall health, and personal preferences. The primary choices are: ● Active Surveillance: For low-risk cancer in older men, where active surveillance is preferred to treatment right away ● Surgery: Radical prostatectomy (removal of the prostate) is commonly performed when cancer is localized ● Radiation Therapy: External beam and internal radiation (brachytherapy) are utilized ● Hormone Therapy: Reduces testosterone levels, which prostate cancer requires for growth ● Chemotherapy and Immunotherapy: Applied in case of advanced or resistant diseases New methods such as robotic surgery and targeted therapy are becoming increasingly popular in top Indian hospitals on par with western hospitals, providing greater precision and quick recovery. Life after diagnosis Prostate cancer diagnosis can be emotionally devastating. The good news is that survival rates are excellent, particularly if it is diagnosed early. In a well functioning man, early localized prostate cancer has a 5-year survival rate of more than 98%. After treatment, some men will have problems such as incontinence or erectile dysfunction. Rehabilitation, physiotherapy, counseling, and drugs can control these problems. Support groups, increasingly available in India's cities, also offer emotional support and solidarity. Breaking the silence In Indian society, where discussions about men's health — particularly below-the-belt matters — remain whispered, awareness is the priority. Men need to be motivated to open up, get regular checks, and make their wellbeing a priority equally as that of their families. Your life is important. Get tested. Speak with your physician. Live stronger. Dr. Chandan MN - MCh Urology - Consultant Apollo Hospital Sheshadripuram, Bengaluru


Hans India
3 days ago
- Hans India
Researchers say new vaccine can protect babies from serious lung infection
London: New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection. Researchers found the respiratory syncytial virus (RSV) vaccine, introduced across the UK in late summer 2024, led to a 72 per cent reduction in babies hospitalised with the virus if mothers were vaccinated. The findings, published in the journal The Lancet Child and Adolescent Health, are the first to show the real-world effectiveness of the vaccine in pregnant women in the UK. Uptake of the jab among pregnant women could help to limit the number of sick babies each winter, reducing hospital pressures, experts say. RSV is a common virus that causes coughs and colds but can lead to a severe lung infection called bronchiolitis, which can be dangerous in babies, with some requiring admission to intensive care. The virus is the main infectious cause of hospitalisation for babies in the UK and globally. The research team, led by the Universities of Edinburgh and Leicester, recruited 537 babies across England and Scotland who had been admitted to hospital with severe respiratory disease in the winter of 2024-2025, the first season of vaccine implementation. 391 of the babies tested positive for RSV. Mothers of babies who did not have RSV were two times more likely to have received the vaccine before delivery than the mothers of RSV-positive babies – 41 per cent compared with 19 per cent. Receiving the vaccine more than 14 days before delivery offered a higher protective effect, with a 72 per cent reduction in hospital admissions compared with 58 per cent for infants whose mothers were vaccinated at any time before delivery. Experts recommend getting vaccinated as soon as possible from 28 weeks of pregnancy to provide the best protection, as this allows more time for the mother to generate and pass on protective antibodies to the baby, but the jab can be given up to birth.